Google Chrome
Safari
Firefox
Edge
News / Dec 19, 2022
Season's Greetings 2022
All of us at Hovione wish you a 2023 filled with hope and joy.
Search
Press Release / Dec 14, 2022
Hovione and GEA announce a strategic collaboration to advance Continuous Tableting
Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting.
Press Clipping / Jan 04, 2023
Hovione and GEA aim to increase adoption of continuous tableting
Outsourcing-Pharma, 4 January 2023
Press Release / Jan 17, 2023
Hovione is recognized as a Top Employer 2023
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Press Release / Mar 07, 2023
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Press Clipping / Mar 14, 2023
Hovione receives the 2023 CDMO Leadership Award in all six categories and is champion in Compatibility and Expertise
Teknoscienze, 13 March 2023
Press Release / Mar 20, 2023
Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics have entered a strategic partnership to expand the use of Ripple's Epidel® platform beyond ophthalmic applications.
Press Release / Mar 22, 2023
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
This partnership will create an opportunity for the pharmaceutical industry to develop and manufacture clinical materials and secure industrial scale production under cGMP with Hovione, using Laxxon Medical’s 3D screen printing technology.